MAIA MAIA Biotechnology, Inc. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
15:28
Sep 09
r/biotech_stocks
MAIA story stock, no institutional interest, wait
The author sees zero participation by biotech institutional investors as a huge red flag, since those groups have teams dedicated to combing through small-cap oncology opportunities and have all passed on MAIA. Ownership being primarily insiders and retail is a tell of its own, a classic formation of a story stock. The author has no position and suggests it is probably a good idea to wait a while.
MAIA MAIA Biotechnology, Inc. Avoid — —
14:53
Sep 09
r/pennystocks
MAIA partnership claims false, self-funded red flag
The author argues the bullish MAIA thesis is flawed because the company does not actually have the major partnerships (Regeneron, Roche, BeOne) that the original post claims. They note the company is self-funded rather than funded through strategic partnerships, which they view as a significant red flag. The author also acknowledges most bio plays are binary events, which they say makes their concerns weigh even more heavily.
MAIA MAIA Biotechnology, Inc. Avoid — —
10:52
Sep 09
r/pennystocks
MAIA funded through Phase 3, dilution overblown
Author argues MAIA is funded for the entirety of Phase 3, with cash and burn rate extending to roughly end of 2027, so near-term dilution fears are misplaced. If the company has conviction in its results, the stock should appreciate by then, reducing the required size of any dilution. Main risk implied is that results disappoint and the stock does not appreciate, forcing larger dilution.
MAIA MAIA Biotechnology, Inc. Long 1ST — —
Log in to see ideas

About MAIA Investor Commentary

Across the available history and selected sources, Buzzberg tracks MAIA (MAIA Biotechnology, Inc.) across 2 sources: 5 bullish vs 0 bearish calls from 7 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 10 total trade ideas tracked. Latest voices: u/DieOnYourFeat, u/Curious_Wafer6169, u/bptbay.